CONMED (CNMD) PT Raised to $45 at Piper Sandler
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $44.69 -1.61%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on CONMED (NYSE: CNMD) to $45.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- RBC Capital Downgrades LVMH (MC:FP) (LVMUY) to Sector Perform
- Kering SA (KER:FP) (PPRUY) PT Lowered to EUR280 at RBC Capital
- Innovent Biologics Inc. (1801:HK) (IVBXF) PT Raised to HK$128 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
